Heart risk blood test study halted after just 12 participants
NCT ID NCT04836117
First seen Apr 26, 2026 · Last updated May 19, 2026 · Updated 4 times
Summary
This study looked at whether a new blood test, called SomaSignal, could help doctors make better treatment decisions for people at higher risk of heart disease. The plan was to enroll over 200 adults aged 40-80, but the study was stopped early after only 12 people joined. Researchers wanted to see if knowing the test results led to changes in medications or lifestyle advice.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTH BEHAVIOR are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Intermountain Medical Center
Salt Lake City, Utah, 84107, United States
Conditions
Explore the condition pages connected to this study.